Author:
Van Cutsem Eric,Yoshino Takayuki,Hocke Julia,Oum'Hamed Zohra,Studeny Matus,Tabernero Josep
Subject
Gastroenterology,Oncology
Reference15 articles.
1. Metastatic colorectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Van Cutsem;Ann Oncol,2014
2. Cancer treatment and survivorship statistics, 2014;DeSantis;CA Cancer J Clin,2014
3. What could nintedanib (BIBF 1120), a triple inhibitor of VEGFR, PDGFR, and FGFR, add to the current treatment options for patients with metastatic colorectal cancer?;Capdevila;Crit Rev Oncol Hematol,2014
4. Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial;Grothey;Lancet,2013
5. Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancer;Loupakis;Br J Cancer,2011
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献